This report goes into detail about the Prescription Drug User Fee Act of 1992. It relays the benefits of the act, as well as discuss the flaw in regards to other forms of drug development.
Serving as both a federal and a state depository library, the UNT Libraries Government Documents Department maintains millions of items in a variety of formats. The department is a member of the FDLP Content Partnerships Program and an Affiliated Archive of the National Archives.
Descriptive information to help identify this report.
Follow the links below to find similar items on the Digital Library.
Description
This report goes into detail about the Prescription Drug User Fee Act of 1992. It relays the benefits of the act, as well as discuss the flaw in regards to other forms of drug development.
This report is part of the following collection of related materials.
Congressional Research Service Reports
The Congressional Research Service (CRS) is the public policy research arm of Congress. This legislative branch agency works exclusively for Members of Congress, their committees and their staff. This collection includes CRS reports from the mid-1960's through 2018—covering a variety of topics from agriculture to foreign policy to welfare.
Cantor, David J.Prescription Drug User Fee Act of 1992: Effects On Bringing New Drugs To Market,
report,
September 12, 1997;
Washington D.C..
(https://digital.library.unt.edu/ark:/67531/metadc812985/:
accessed September 9, 2026),
University of North Texas Libraries, UNT Digital Library, https://digital.library.unt.edu;
crediting UNT Libraries Government Documents Department.